SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-15-050448
Filing Date
2015-08-18
Accepted
2015-08-18 16:34:50
Documents
2
Effectiveness Date
2015-08-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A v418514_defa14a.htm DEFA14A 113171
2 GRAPHIC line.gif GRAPHIC 43
  Complete submission text file 0001144204-15-050448.txt   114468
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEFA14A | Act: 34 | File No.: 001-36288 | Film No.: 151061726
SIC: 2834 Pharmaceutical Preparations